Results 251 to 260 of about 314,005 (303)

Long-term risk of de novo malignancy with tumor necrosis factor alpha (TNF) inhibitor immunosuppression: a multicenter, retrospective cohort study. [PDF]

open access: yesJ Inflamm (Lond)
Driscoll CB   +12 more
europepmc   +1 more source

[Tumor necrosis factor alpha. Biological aspects].

open access: yesGiornale italiano di chemioterapia, 1989
Human Tumor Necrosis Factor-alpha (TNF-alpha) is a multifaceted cytokine mainly produced by activated monocytes or macrophages. Several recent studies have shown that TNF-alpha can exert a variety of in vitro and in vivo effects including: modulation of normal and malignant haemopoiesis, antineoplastic activity, activation of neutrophils, induction of ...
MELONI, FEDERICA
core   +4 more sources

Tumor necrosis factor alpha in mycobacterial infection

Seminars in Immunology, 2014
Tumor necrosis factor alpha (TNF-α) is a critical immune mediator in protection against and pathology of tuberculosis (TB). TNF-α had been found to be associated with TB when it was originally identified as cachexin and until today TB research continues to unveil novel roles of this cytokine of highest relevance for the disease process and for novel ...
Dorhoi, A., Kaufmann, S.
openaire   +3 more sources

Role of tumor necrosis factor alpha in asthma

Immunology and Allergy Clinics of North America, 2004
Asthma is a heterogeneous disease in which various cytokines orchestrate airway inflammation. Tumor necrosis alpha (TNF-alpha) is a proinflammatory cytokine that has been implicated in the modulation of inflammation in various diseases, including asthma. Although TNF-alpha blocking strategies have been an effective therapeutic modality in diseases such
Babu, K. Suresh   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy